Prior to joining FAU, Flynn served as Associate Dean for Research in the College of Health Sciences at the University of Delaware. In that role, he helped grow the research enterprise by 60 percent, promoted the development of invention disclosures and patent applications by faculty and developed undergraduate entrepreneurial programs and research programs. He also served as the founding Associate Dean for Research and Economic Development at The Commonwealth Medical College (now, The Geisinger Medical college), a new medical school in Scranton, PA. He oversaw all research activities at the college, including sponsored programs, research compliance, interactions with industry and technology transfer.
Flynn spent 17 years at West Virginia University, where he served as a Professor and Deputy Director of the Mary Babb Randolph Cancer Center. During his career, he has been awarded more than $40 million in research funding, mostly federal grants. The National Institutes of Health has funded Flynn’s research program for more than 20 years to study signals that regulate invasion in breast cancer. During this tenure at WVU, he was Director of a Center of Biomedical Research Excellence for Cancer Cell Biology, developed mentoring programs for junior faculty, organized core facilities, served as principal investigator on a training grant in cancer nanotechnology and served as coordinator of the M.D./Ph.D. training program.
He has published 72 research articles and is the scientific founder of a successful biotech company, Protea Biosciences, Inc., based in Morgantown, West Virginia. The company employs more than 50 people and he served on its board of directors for 12 years. Flynn has also served on an editorial board, advisory committees for NIH and Association of American Medical Colleges, and has been an active member of NIH study sections.
For more than 20 years, Flynn taught medical students, graduate and undergraduate students. He was nominated as teacher of the year at WVU medical school five times and received the award twice. He also developed graduate and undergraduate courses, a doctoral degree program curriculum in cancer cell biology at WVU and developed a Professional Science of Masters degree program, approved by the Pennsylvania Department of Education.
Originally from Annapolis, MD, Dr. Flynn obtained his B.S. in microbiology from the University of Maryland, College Park (1981) and his Ph.D. in virology from North Carolina State University (1988). Flynn conducted his post-doctoral studies at the University of Virginia (1992) in oncogenes and signal transduction.